<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05114382</url>
  </required_header>
  <id_info>
    <org_study_id>CP-00003</org_study_id>
    <nct_id>NCT05114382</nct_id>
  </id_info>
  <brief_title>An Evaluation of the Safety and Performance of the CathVision Cube® System</brief_title>
  <official_title>An Evaluation of the Safety and Performance of the CathVision Cube® System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CathVision ApS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TRIQ GROUP Wherry &amp; Klaffke GbR</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CathVision ApS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate the safety and technical performance of the CathVision&#xD;
      Cube® System. The secondary objective is to benchmark the intracardiac electrogram signal&#xD;
      quality compared to commercially available systems in patients undergoing assessment and&#xD;
      ablation of cardiac arrhythmias.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, single center, open-label, single arm study to evaluate the safety and&#xD;
      technical performance of the CathVision Cube® system.&#xD;
&#xD;
      Patients undergoing assessment and ablation of cardiac arrhythmias, by Electro Physiology&#xD;
      (EP) procedure, and who meet all inclusion criteria will be enrolled in the study and undergo&#xD;
      the EP procedure. Intracardiac signals will be passively recorded using the CathVision Cube®&#xD;
      System in parallel with a commercial (CE marked) EP recording system and later compared and&#xD;
      evaluated. The investigational device will not be used for direct clinical care decisions or&#xD;
      therapy. The EP procedure will be guided by the study site Standards Of Care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2, 2020</start_date>
  <completion_date type="Actual">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 9, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A prospective, single center, open-label, single arm study to evaluate the safety and technical performance of the CathVision Cube® system.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from major adverse events, evaluated at hospital discharge.</measure>
    <time_frame>From EP procedure to hospital discharge is 1 day</time_frame>
    <description>Freedom from major adverse events, evaluated at hospital discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recording low-voltage electrograms</measure>
    <time_frame>Duration of the EP procedure can take up to 6 hours</time_frame>
    <description>Recording low-voltage electrograms under 20uV amplitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Primary Performance endpoint of study will be evaluated as technical success of CathVision Cube® system to collect and record intracardiac signals during EP procedures</measure>
    <time_frame>Duration of the EP procedure can take up to 6 hours</time_frame>
    <description>Logging time for arrhythmia termination / block</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compatibility of Cube System with commercially available 3D mapping system</measure>
    <time_frame>Duration of the EP procedure can take up to 6 hours</time_frame>
    <description>Assessing compatibility of Cube System with commercially available 3D mapping system with available intracardiac catheters. Compatibility is assessed by that the Cube System does not introduce a visual detectable distortion on the commercial available 3D mapping systems</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>A prospective, multi-center, open-label, single arm study</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients undergoing assessment and ablation of cardiac arrhythmiast. who are scheduled for an electrophysiology (EP) procedure and meet all inclusion criteria will be enrolled in the study and undergo the EP procedure. Intracardiac signals will be passively recorded using the CathVision Cube® System in parallel with the commercial (CE marked) EP recording system for post procedure evaluation. The investigational device will not be used for direct clinical care decisions or therapy. The EP procedure will be guided by the study site Standards Of Care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EP Procedure</intervention_name>
    <description>Intracardiac signals will be passively recorded using CathVision Cube® System in parallel with the commercial (CE marked) EP recording system during a scheduled electrophysiology procedure</description>
    <arm_group_label>A prospective, multi-center, open-label, single arm study</arm_group_label>
    <other_name>electrophysiology procedure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient indicated by investigator for catheter ablation or diagnostic&#xD;
             electrophysiology procedure.&#xD;
&#xD;
          -  Male or non-pregnant female aged ≥18 years. Female patients of childbearing potential&#xD;
             must have a negative pregnancy test (per site standard test) within 7 days prior to&#xD;
             index procedure.&#xD;
&#xD;
          -  Able and willing to directly provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient inability to understand or refusal to sign informed consent.&#xD;
&#xD;
          -  Pregnant or nursing patients and those who plan pregnancy in the period up to 1 month&#xD;
             following the index procedure.&#xD;
&#xD;
          -  Current participation in another investigational drug or device study that interferes&#xD;
             with this study.&#xD;
&#xD;
          -  Patient is a prisoner.&#xD;
&#xD;
          -  Patients who in the opinion of the physician are not candidates for this study. Prior&#xD;
             atrial septal defect (ASD) or patent foramen ovale (PFO) closure with a device using a&#xD;
             transcatheter percutaneous approach.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josef Kautzner, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>IKEM, Prague, Czech Republic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter K Jacobsen, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Righospitalet, Copenhagen, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IKEM, Institue of Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>14021 Praha 4</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 16, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>pulmonary vein isolation</keyword>
  <keyword>radiofrequency</keyword>
  <keyword>cryo balloon</keyword>
  <keyword>ablation</keyword>
  <keyword>software</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 24, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT05114382/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

